Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of an In Vitro Diagnostic Next-Generation Sequencing Assay with Sanger Sequencing for HIV-1 Genotypic Resistance Testing
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 56, Issue 6, Pages e00105-18
Publisher
American Society for Microbiology
Online
2018-03-30
DOI
10.1128/jcm.00105-18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir
- (2017) Marine Perrier et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1–Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing
- (2017) Dana S Clutter et al. JOURNAL OF INFECTIOUS DISEASES
- The Role of HIV-1 Drug-Resistant Minority Variants in Treatment Failure
- (2017) Natalia Stella-Ascariz et al. JOURNAL OF INFECTIOUS DISEASES
- Next-Generation Human Immunodeficiency Virus Sequencing for Patient Management and Drug Resistance Surveillance
- (2017) Marc Noguera-Julian et al. JOURNAL OF INFECTIOUS DISEASES
- Comparison of HIV-1 drug-resistance genotyping by ultra-deep sequencing and sanger sequencing using clinical samples
- (2017) Mary-Anne Trabaud et al. JOURNAL OF MEDICAL VIROLOGY
- MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing
- (2017) Michael Huber et al. JOURNAL OF VIROLOGICAL METHODS
- Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation
- (2017) Roger Paredes et al. PLoS One
- Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure
- (2016) Fred Kyeyune et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants
- (2016) M. Noguera-Julian et al. CLINICAL MICROBIOLOGY AND INFECTION
- Deep Sequencing of HIV-1 RNA and DNA in Newly Diagnosed Patients with Baseline Drug Resistance Showed No Indications for Hidden Resistance and Is Biased by Strong Interference of Hypermutation
- (2016) Kenny Dauwe et al. JOURNAL OF CLINICAL MICROBIOLOGY
- HIV-1 Protease, Reverse Transcriptase, and Integrase Variation
- (2016) Soo-Yon Rhee et al. JOURNAL OF VIROLOGY
- Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation
- (2016) Krista A. Delviks-Frankenberry et al. PLoS Pathogens
- Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey
- (2016) Santiago Ávila-Ríos et al. Lancet HIV
- Primer ID Informs Next-Generation Sequencing Platforms and Reveals Preexisting Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Coding Domain
- (2015) Jessica R. Keys et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- HIV Drug Resistance Testing by High-Multiplex “Wide” Sequencing on the MiSeq Instrument
- (2015) H. R. Lapointe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations
- (2015) Shuntai Zhou et al. JOURNAL OF VIROLOGY
- HIV-1 genotypic drug resistance testing: digging deep, reaching wide?
- (2015) Kristel Van Laethem et al. Current Opinion in Virology
- Improved detection of artifactual viral minority variants in high-throughput sequencing data
- (2015) Matthijs R. A. Welkers et al. Frontiers in Microbiology
- Comparison of ultra-deep versus Sanger sequencing detection of minority mutations on the HIV-1 drug resistance interpretations after virological failure
- (2014) Sofiane Mohamed et al. AIDS
- Improved Prediction of Salvage Antiretroviral Therapy Outcomes Using Ultrasensitive HIV-1 Drug Resistance Testing
- (2014) Christian Pou et al. CLINICAL INFECTIOUS DISEASES
- Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing
- (2014) Alessandro Cozzi-Lepri et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Low-Frequency Nevirapine (NVP)–Resistant HIV-1 Variants Are Not Associated With Failure of Antiretroviral Therapy in Women Without Prior Exposure to Single-Dose NVP
- (2014) Valerie F. Boltz et al. JOURNAL OF INFECTIOUS DISEASES
- Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity
- (2014) Marieke Pingen et al. Retrovirology
- Persistence of HIV-1 Transmitted Drug Resistance Mutations
- (2013) Hannah Castro et al. JOURNAL OF INFECTIOUS DISEASES
- HIV-1 Drug-Resistant Minority Variants: Sweating the Small Stuff
- (2013) J. Z. Li JOURNAL OF INFECTIOUS DISEASES
- Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance
- (2012) Farbod Babrzadeh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Automating HIV Drug Resistance Genotyping with RECall, a Freely Accessible Sequence Analysis Tool
- (2012) Conan K. Woods et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure
- (2011) Jonathan Z. Li JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes
- (2011) Vivek Jain et al. JOURNAL OF INFECTIOUS DISEASES
- Detection of Minority Resistance during Early HIV-1 Infection: Natural Variation and Spurious Detection rather than Transmission and Evolution of Multiple Viral Variants
- (2011) S. Gianella et al. JOURNAL OF VIROLOGY
- Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID
- (2011) C. B. Jabara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nucleic Acid Template and the Risk of a PCR-Induced HIV-1 Drug Resistance Mutation
- (2010) Vici Varghese et al. PLoS One
- Minority Variants Associated with Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase Inhibitors
- (2009) Vici Varghese et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes
- (2009) Birgitte B. Simen et al. JOURNAL OF INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started